Instadose Announces Strategic JV Partner in India
Press release content from Accesswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Press release content from Accesswire. The AP news staff was not involved in its creation.
CHESAPEAKE, VA / ACCESSWIRE / October 27, 2021 / Instadose Pharma Corp. (formerly Mikrocoze) is proud to announce that Instadose Pharma Corp (Canada) ("Instadose Canada", "Instadose" or the "Company")
CMA fines pharma firm over pricing of crucial thyroid drug The CMA has imposed over £100 million in fines after Advanz inflated the price of thyroid tablets, causing the NHS and patients to lose out. From: 29 July 2021 Advanz increased the price of thyroid tablet packs from £20 in 2009 to £248 in 2017 – an increase of 1,110%. Latest CMA fine “sends a clear message” to the pharma sector that breaking the law will not be tolerated. Following an investigation, the Competition and Markets Authority (CMA) has found that from 2009 until 2017 the pharmaceutical company Advanz charged ex...
Company” or " RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“ Canapar”) and a wholly-owned subsidiary of the Company on May 11, 2021, that provides for the acquisition of all the common shares of Canapar (“ Canapar Shares”) that the Company does not currently own in exchange for an aggregate of approximately 21,904,095 common shares RAMM at a deemed value of $1.20 per Ramm Share (“ RAMM Shares”) for a total ...